Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours Β· Estimated delivery Aug 7 - Aug 12
Although all are queued up at the starting line, the competition for the first generic drug is relatively clear
The in vivo pharmacokinetic investigations showed that the drug concentration in the brain was higher with Nano structured lipid carriers (NLC) as compared to the free medication given intravenously
Phase 1b/2a Subcutaneous Formulation (Obesity) Published: The Lancet, June 2025 Participants: 125 adults with overweight or obesity (BMI 27.039.9), aged 1855 Duration: Up to 36 weeks Dosing: Once-weekly subcutaneous amycretin, up to 60 mg Results: - Up to 22% absolute weight loss at 36 weeks (highest dose group) - Placebo-adjusted difference: approximately 24% - No weight-loss plateau observed at study end Safety: 81% of the 89 participants who reported a TEAE had gastrointestinal events
Proc Natl Acad Sci U S A (2003) 100(5):28427
This is why labeling your vial with the concentration is critical
Long-chain acylcarnitines determine ischaemia/reperfusion-induced damage in heart mitochondria
US$ 20.11
US$ 26.60
US$ 24.14
US$ 20.30
US$ 21.27
US$ 22.20
